ALK positive patients: 5 trials - ALEX - YO29449 - MO29750 - J-ALEX - ALUR
| alectinib vs chemotherapy | No demonstrated result suggested progression or death (progression free survival PFS) by 85% (not demonstrated) | |
| alectinib vs crizotinib | progression or death (progression free survival PFS) by 53% (fully demonstrated) | |
| alectinib vs premetrexed or docetaxel | No demonstrated result |
-
About
-
Browse pathology
|
treatment
-
Site map
-
Credits
Made with in Lyon
-
Contact us
-
Privacy policy
-
